Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis.

Cordero A, Kanojia D, Miska J, Panek WK, Xiao A, Han Y, Bonamici N, Zhou W, Xiao T, Wu M, Ahmed AU, Lesniak MS.

Oncogene. 2019 Jul 19. doi: 10.1038/s41388-019-0893-4. [Epub ahead of print]

PMID:
31324889
2.

Chemotherapeutic Stress Induces Transdifferentiation of Glioblastoma Cells to Endothelial Cells and Promotes Vascular Mimicry.

Baisiwala S, Auffinger B, Caragher SP, Shireman JM, Ahsan R, Lee G, Hasan T, Park C, Saathoff MR, Christensen AC, Ahmed AU.

Stem Cells Int. 2019 Jun 18;2019:6107456. doi: 10.1155/2019/6107456. eCollection 2019.

3.

Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations.

Fares J, Kanojia D, Rashidi A, Ahmed AU, Balyasnikova IV, Lesniak MS.

Clin Breast Cancer. 2019 Jun 5. pii: S1526-8209(19)30262-9. doi: 10.1016/j.clbc.2019.05.018. [Epub ahead of print] Review.

PMID:
31262686
4.

Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective.

Manna PR, Ahmed AU, Yang S, Narasimhan M, Cohen-Tannoudji J, Slominski AT, Pruitt K.

Cancers (Basel). 2019 May 4;11(5). pii: E623. doi: 10.3390/cancers11050623.

5.

HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma.

Miska J, Lee-Chang C, Rashidi A, Muroski ME, Chang AL, Lopez-Rosas A, Zhang P, Panek WK, Cordero A, Han Y, Ahmed AU, Chandel NS, Lesniak MS.

Cell Rep. 2019 Apr 2;27(1):226-237.e4. doi: 10.1016/j.celrep.2019.03.029.

6.

Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.

Hasan T, Caragher SP, Shireman JM, Park CH, Atashi F, Baisiwala S, Lee G, Guo D, Wang JY, Dey M, Wu M, Lesniak MS, Horbinski CM, James CD, Ahmed AU.

Cell Death Dis. 2019 Mar 29;10(4):292. doi: 10.1038/s41419-019-1387-6.

7.

Glioblastoma Recurrence and the Role of O6-Methylguanine-DNA Methyltransferase Promoter Methylation.

Storey K, Leder K, Hawkins-Daarud A, Swanson K, Ahmed AU, Rockne RC, Foo J.

JCO Clin Cancer Inform. 2019 Feb;3:1-12. doi: 10.1200/CCI.18.00062.

8.

Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma.

Caragher SP, Shireman JM, Huang M, Miska J, Atashi F, Baisiwala S, Hong Park C, Saathoff MR, Warnke L, Xiao T, Lesniak MS, James CD, Meltzer H, Tryba AK, Ahmed AU.

J Neurosci. 2019 Mar 13;39(11):1982-1993. doi: 10.1523/JNEUROSCI.1589-18.2018. Epub 2019 Jan 16.

PMID:
30651332
9.

Overexpression of the steroidogenic acute regulatory protein in breast cancer: Regulation by histone deacetylase inhibition.

Manna PR, Ahmed AU, Vartak D, Molehin D, Pruitt K.

Biochem Biophys Res Commun. 2019 Feb 5;509(2):476-482. doi: 10.1016/j.bbrc.2018.12.145. Epub 2018 Dec 27.

PMID:
30595381
10.

A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model.

Kim JW, Kane JR, Panek WK, Young JS, Rashidi A, Yu D, Kanojia D, Hasan T, Miska J, Gómez-Lim MA, Ulasov IV, Balyasnikova IV, Ahmed AU, Wainwright DA, Lesniak MS.

Neurotherapeutics. 2018 Oct;15(4):1127-1138. doi: 10.1007/s13311-018-0650-3.

PMID:
30027430
11.

Mechanisms and consequences of constitutive activation of integrin-linked kinase in acute myeloid leukemia.

Alasseiri M, Ahmed AU, Williams BRG.

Cytokine Growth Factor Rev. 2018 Oct;43:1-7. doi: 10.1016/j.cytogfr.2018.06.001. Epub 2018 Jun 7. Review.

PMID:
29903521
12.

Estimating Angle-of-Arrival and Time-of-Flight for Multipath Components Using WiFi Channel State Information.

Ahmed AU, Arablouei R, Hoog F, Kusy B, Jurdak R, Bergmann N.

Sensors (Basel). 2018 May 29;18(6). pii: E1753. doi: 10.3390/s18061753.

13.

Monoamines in glioblastoma: complex biology with therapeutic potential.

Caragher SP, Hall RR, Ahsan R, Ahmed AU.

Neuro Oncol. 2018 Jul 5;20(8):1014-1025. doi: 10.1093/neuonc/nox210.

14.

Integrin-Linked Kinase Expression in Myeloid Cells Promotes Inflammatory Signaling during Experimental Colitis.

Ahmed AU, Yim HCH, Alorro M, Ernst M, Williams BRG.

J Immunol. 2017 Aug 9. pii: ji1700125. doi: 10.4049/jimmunol.1700125. [Epub ahead of print]

PMID:
28794235
15.

Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.

Yu D, Khan OF, Suvà ML, Dong B, Panek WK, Xiao T, Wu M, Han Y, Ahmed AU, Balyasnikova IV, Zhang HF, Sun C, Langer R, Anderson DG, Lesniak MS.

Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6147-E6156. doi: 10.1073/pnas.1701911114. Epub 2017 Jul 10.

16.

Rogue one: another faction of the Wnt empire implicated in assisting GBM progression.

Ahsan R, Baisiwala S, Ahmed AU.

Transl Cancer Res. 2017 Mar;6(Suppl 2):S321-S327. doi: 10.21037/tcr.2017.03.29.

17.

Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance.

Lee G, Hall RR 3rd, Ahmed AU.

J Stem Cell Res Ther. 2016 Oct;6(10). pii: 363. Epub 2016 Oct 26.

18.

Dysregulation of Aromatase in Breast, Endometrial, and Ovarian Cancers: An Overview of Therapeutic Strategies.

Manna PR, Molehin D, Ahmed AU.

Prog Mol Biol Transl Sci. 2016;144:487-537. doi: 10.1016/bs.pmbts.2016.10.002. Epub 2016 Oct 26. Review.

PMID:
27865465
19.

Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model.

Lee G, Auffinger B, Guo D, Hasan T, Deheeger M, Tobias AL, Kim JY, Atashi F, Zhang L, Lesniak MS, James CD, Ahmed AU.

Mol Cancer Ther. 2016 Dec;15(12):3064-3076. Epub 2016 Oct 7. Erratum in: Mol Cancer Ther. 2017 Jun;16(6):1199.

20.

Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma.

Dey M, Yu D, Kanojia D, Li G, Sukhanova M, Spencer DA, Pituch KC, Zhang L, Han Y, Ahmed AU, Aboody KS, Lesniak MS, Balyasnikova IV.

Stem Cell Reports. 2016 Sep 13;7(3):471-482. doi: 10.1016/j.stemcr.2016.07.024. Epub 2016 Sep 1.

21.

CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.

Chang AL, Miska J, Wainwright DA, Dey M, Rivetta CV, Yu D, Kanojia D, Pituch KC, Qiao J, Pytel P, Han Y, Wu M, Zhang L, Horbinski CM, Ahmed AU, Lesniak MS.

Cancer Res. 2016 Oct 1;76(19):5671-5682. Epub 2016 Aug 16.

22.

Dogs are man's best friend: in sickness and in health.

Bentley RT, Ahmed AU, Yanke AB, Cohen-Gadol AA, Dey M.

Neuro Oncol. 2017 Mar 1;19(3):312-322. doi: 10.1093/neuonc/now109. Review.

23.

Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters.

Kim JW, Auffinger B, Spencer DA, Miska J, Chang AL, Kane JR, Young JS, Kanojia D, Qiao J, Mann JF, Zhang L, Wu M, Ahmed AU, Aboody KS, Strong TV, Hébert CD, Lesniak MS.

J Transl Med. 2016 May 16;14(1):134. doi: 10.1186/s12967-016-0895-8.

24.

Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions.

Kim J, Hall RR, Lesniak MS, Ahmed AU.

Viruses. 2015 Nov 27;7(12):6200-17. doi: 10.3390/v7122921. Review.

25.

Transcriptional Activation of Inflammatory Genes: Mechanistic Insight into Selectivity and Diversity.

Ahmed AU, Williams BR, Hannigan GE.

Biomolecules. 2015 Nov 11;5(4):3087-111. doi: 10.3390/biom5043087. Review.

26.

MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells.

Alexiades NG, Auffinger B, Kim CK, Hasan T, Lee G, Deheeger M, Tobias AL, Kim J, Balyasnikova I, Lesniak MS, Aboody K, Ahmed AU.

Stem Cell Res. 2015 Nov;15(3):598-607. doi: 10.1016/j.scr.2015.10.005. Epub 2015 Oct 22.

27.

Antibacterial Effect of Curcuma longa (Turmeric) Against Staphylococcus aureus and Escherichia coli.

Afrose R, Saha SK, Banu LA, Ahmed AU, Shahidullah AS, Gani A, Sultana S, Kabir MR, Ali MY.

Mymensingh Med J. 2015 Jul;24(3):506-15.

PMID:
26329948
28.

Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases.

Kanojia D, Balyasnikova IV, Morshed RA, Frank RT, Yu D, Zhang L, Spencer DA, Kim JW, Han Y, Yu D, Ahmed AU, Aboody KS, Lesniak MS.

Stem Cells. 2015 Oct;33(10):2985-94. doi: 10.1002/stem.2109. Epub 2015 Aug 11.

29.

A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma.

Kim JW, Kane JR, Young JS, Chang AL, Kanojia D, Morshed RA, Miska J, Ahmed AU, Balyasnikova IV, Han Y, Zhang L, Curiel DT, Lesniak MS.

Hum Gene Ther. 2015 Sep;26(9):635-46. doi: 10.1089/hum.2015.008. Epub 2015 Aug 11.

30.

The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.

Auffinger B, Spencer D, Pytel P, Ahmed AU, Lesniak MS.

Expert Rev Neurother. 2015;15(7):741-52. doi: 10.1586/14737175.2015.1051968. Epub 2015 May 31. Review.

31.

Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.

Dey M, Chang AL, Miska J, Wainwright DA, Ahmed AU, Balyasnikova IV, Pytel P, Han Y, Tobias A, Zhang L, Qiao J, Lesniak MS.

J Immunol. 2015 Jul 1;195(1):367-76. doi: 10.4049/jimmunol.1401607. Epub 2015 May 29.

32.

A regulatory approach on serum bilirubin level in subjects with impaired glucose tolerance.

Haque MM, Shahjahan M, Haque MS, Ahmed AU, Absar N, Saha SK.

Mymensingh Med J. 2015 Apr;24(2):326-33.

PMID:
26007261
33.

Neural stem cell-mediated delivery of oncolytic adenovirus.

Kim JW, Kane JR, Young JS, Chang AL, Kanojia D, Qian S, Spencer DA, Ahmed AU, Lesniak MS.

Curr Protoc Hum Genet. 2015 Apr 1;85:13.11.1-9. doi: 10.1002/0471142905.hg1311s85.

34.

βIII-Tubulin Regulates Breast Cancer Metastases to the Brain.

Kanojia D, Morshed RA, Zhang L, Miska JM, Qiao J, Kim JW, Pytel P, Balyasnikova IV, Lesniak MS, Ahmed AU.

Mol Cancer Ther. 2015 May;14(5):1152-61. doi: 10.1158/1535-7163.MCT-14-0950. Epub 2015 Feb 27.

35.

Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction.

Morshed RA, Gutova M, Juliano J, Barish ME, Hawkins-Daarud A, Oganesyan D, Vazgen K, Yang T, Annala A, Ahmed AU, Aboody KS, Swanson KR, Moats RA, Lesniak MS.

Cancer Gene Ther. 2015 Jan;22(1):55-61. doi: 10.1038/cgt.2014.72. Epub 2014 Dec 19.

36.

Intermittent prophylaxis of recurrent febrile seizures with clobazam versus diazepam.

Sattar S, Saha SK, Parveen F, Banu LA, Momen A, Ahmed AU, Quddush MR, Karim MM, Begum SA, Haque MA, Hoque MR.

Mymensingh Med J. 2014 Oct;23(4):676-85.

PMID:
25481585
37.

A novel user classification method for femtocell network by using affinity propagation algorithm and artificial neural network.

Ahmed AU, Islam MT, Ismail M, Kibria S, Arshad H.

ScientificWorldJournal. 2014;2014:253787. doi: 10.1155/2014/253787. Epub 2014 Jul 16.

38.

Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging.

Cheng Y, Dai Q, Morshed RA, Fan X, Wegscheid ML, Wainwright DA, Han Y, Zhang L, Auffinger B, Tobias AL, Rincón E, Thaci B, Ahmed AU, Warnke PC, He C, Lesniak MS.

Small. 2014 Dec 29;10(24):5137-50. doi: 10.1002/smll.201400654. Epub 2014 Aug 8.

39.

Integrin-linked kinase modulates lipopolysaccharide- and Helicobacter pylori-induced nuclear factor κB-activated tumor necrosis factor-α production via regulation of p65 serine 536 phosphorylation.

Ahmed AU, Sarvestani ST, Gantier MP, Williams BR, Hannigan GE.

J Biol Chem. 2014 Oct 3;289(40):27776-93. doi: 10.1074/jbc.M114.574541. Epub 2014 Aug 6.

40.

Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.

Young JS, Morshed RA, Kim JW, Balyasnikova IV, Ahmed AU, Lesniak MS.

Expert Opin Drug Deliv. 2014 Nov;11(11):1733-46. doi: 10.1517/17425247.2014.937420. Epub 2014 Jul 8. Review.

PMID:
25005767
41.

Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?

Dey M, Auffinger B, Lesniak MS, Ahmed AU.

Future Virol. 2013 Jul;8(7):675-693.

42.

Cytomegalovirus and glioma: putting the cart before the horse.

Dey M, Ahmed AU, Lesniak MS.

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):191-9. doi: 10.1136/jnnp-2014-307727. Epub 2014 Jun 6. Review.

PMID:
24906494
43.

Therapeutic cell carriers: a potential road to cure glioma.

Young JS, Kim JW, Ahmed AU, Lesniak MS.

Expert Rev Neurother. 2014 Jun;14(6):651-60. doi: 10.1586/14737175.2014.917964. Review.

PMID:
24852229
44.

Dynamic resource allocation in hybrid access femtocell network.

Ahmed AU, Islam MT, Ismail M, Ghanbarisabagh M.

ScientificWorldJournal. 2014 Mar 20;2014:539720. doi: 10.1155/2014/539720. eCollection 2014.

45.

Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.

Auffinger B, Tobias AL, Han Y, Lee G, Guo D, Dey M, Lesniak MS, Ahmed AU.

Cell Death Differ. 2014 Jul;21(7):1119-31. doi: 10.1038/cdd.2014.31. Epub 2014 Mar 7.

46.

Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma.

Thaci B, Ahmed AU, Ulasov IV, Wainwright DA, Nigam P, Auffinger B, Tobias AL, Han Y, Zhang L, Moon KS, Lesniak MS.

Cancer Gene Ther. 2014 Jan;21(1):38-44. doi: 10.1038/cgt.2013.81. Epub 2014 Jan 17.

47.

Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistance.

Deheeger M, Lesniak MS, Ahmed AU.

Cancer Cell Microenviron. 2014;1(5). pii: e295.

48.

Heme oxygenase-1 protects regulatory T cells from hypoxia-induced cellular stress in an experimental mouse brain tumor model.

Dey M, Chang AL, Wainwright DA, Ahmed AU, Han Y, Balyasnikova IV, Lesniak MS.

J Neuroimmunol. 2014 Jan 15;266(1-2):33-42. doi: 10.1016/j.jneuroim.2013.10.012. Epub 2013 Nov 8.

49.

Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors.

Balyasnikova IV, Prasol MS, Ferguson SD, Han Y, Ahmed AU, Gutova M, Tobias AL, Mustafi D, Rincón E, Zhang L, Aboody KS, Lesniak MS.

Mol Ther. 2014 Jan;22(1):140-8. doi: 10.1038/mt.2013.199. Epub 2013 Sep 3.

50.

The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma.

Tobias AL, Thaci B, Auffinger B, Rincón E, Balyasnikova IV, Kim CK, Han Y, Zhang L, Aboody KS, Ahmed AU, Lesniak MS.

Stem Cells Transl Med. 2013 Sep;2(9):655-66. doi: 10.5966/sctm.2013-0039. Epub 2013 Aug 7.

Supplemental Content

Loading ...
Support Center